Highlights

• Baby Bunting recorded FY2026 sales of AU$556.0 million, up 6.5%, with comparable sales increasing 3.5%.
• Pro forma NPAT rose 33.9% to AU$16.1 million, while statutory NPAT grew 17.5% to AU$11.2 million.
• Gross margin reached 41.2%, while EBITDA stood at AU$37.6 million, pointing to stronger operating efficiency.

Why Are Baby Bunting Shares in Focus?Baby Bunting Group Limited (ASX: BBN) has attracted market attention following a 23.2% jump in its share price, taking the current market price (CMP) to AU$1.485. The rally came alongside FY2026 results that indicated improvement across several important financial measures. Revenue from ordinary activities reached AU$556.0 million, representing 6.5% growth, while comparable sales increased 3.5%. Pro forma NPAT expanded to AU$16.1 million, up 33.9%, and statutory NPAT increased to AU$11.2 million.Where Did the Improvement Come From?Profitability strengthened as the retailer generated a gross margin of 41.2%, an improvement of 100 basis points. The second half performed slightly better, delivering a gross margin of 41.4%. EBITDA reached AU$37.6 million and represented 6.8% of sales, compared with a lower margin in the previous year.Store upgrades also contributed to the operational improvement. The company had 15 refurbished Store of the Future locations trading, while refurbished stores achieved average sales growth of 18% during FY2026.Can New Sales Channels Support the Next Phase?Online operations continued to gain importance, generating AU$140.5 million in sales and contributing 25.3% of group sales. Private-label and exclusive products also increased their contribution to 50.3% of total sales, giving Baby Bunting greater scope to differentiate its offering and improve margins.Operating cash conversion reached 96.4%. However, investment activity remained elevated, with capital expenditure of AU$44.5 million. Net debt ended the period at AU$16.2 million, compared with AU$4.5 million previously. No dividend was declared for FY2026.What Could Shape BBN’s Next Move?Baby Bunting intends to undertake another 10-12 store refurbishments during FY2027 and continues to target a long-term EBITDA margin above 10%. The uncertain consumer environment remains an important variable, particularly for higher-priced products.Following the 23.2% rally, attention could now shift from the FY2026 recovery to whether Baby Bunting can maintain its improving margins and earnings trajectory.Note- All data presented is based on information available at the time of writing.Disclaimer for Kapitales ResearchThe materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise. 

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au